TY - JOUR
T1 - Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid Neoplasia
AU - Paes, John E.
AU - Ringel, Matthew D.
PY - 2008/6
Y1 - 2008/6
N2 - The phosphatidylinositol 3-kinase (PI3K) signaling pathway is an important regulator of many cellular events, including apoptosis, proliferation, and motility. Enhanced activation of this pathway can occur through several mechanisms, such as inactivation of its negative regulator, phosphatase and tensin homolog deleted on chromosome ten (PTEN), and activating mutations and gene amplification of the gene encoding the catalytic subunit of PI3K (PIK3CA). These genetic abnormalities have been particularly associated with follicular thyroid neoplasia and anaplastic thyroid cancer, suggesting an important role for PI3K signaling in these disorders. In this article, the role of PI3K pathway activation in thyroid cancer is discussed, with a focus on recent advances.
AB - The phosphatidylinositol 3-kinase (PI3K) signaling pathway is an important regulator of many cellular events, including apoptosis, proliferation, and motility. Enhanced activation of this pathway can occur through several mechanisms, such as inactivation of its negative regulator, phosphatase and tensin homolog deleted on chromosome ten (PTEN), and activating mutations and gene amplification of the gene encoding the catalytic subunit of PI3K (PIK3CA). These genetic abnormalities have been particularly associated with follicular thyroid neoplasia and anaplastic thyroid cancer, suggesting an important role for PI3K signaling in these disorders. In this article, the role of PI3K pathway activation in thyroid cancer is discussed, with a focus on recent advances.
UR - http://www.scopus.com/inward/record.url?scp=43849090932&partnerID=8YFLogxK
U2 - 10.1016/j.ecl.2008.01.001
DO - 10.1016/j.ecl.2008.01.001
M3 - Review article
C2 - 18502332
AN - SCOPUS:43849090932
SN - 0889-8529
VL - 37
SP - 375
EP - 387
JO - Endocrinology and Metabolism Clinics of North America
JF - Endocrinology and Metabolism Clinics of North America
IS - 2
ER -